Ardelyx IPO hits middle of target range, raises $60 million

Biotech company Ardelyx raised $60 million in an IPO on Wednesday and was set to begin trading on Nasdaq on Thursday...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.